Soumyajit Roy (Soum)
@Soum_Roy_RadOnc
Human, #IMG, #RadOnc via @aiims_newdelhi @RushCancer @EdinburghUni (MSc. biostat-epi). Now @RadOncUH @CASECCC. Editor @Advances_ASTRO. #PCSM #Rstats #research.
It wouldn't 've been possible w/out immense support from @jmmrad @WallisCJD @AmarUKishan @HimanshuNagarMD @mishabeltran @NicholasZaorsky @angela_jia_ @aleberlin2 @ASCOPres, Prof Eastham, Prof Gleave, Prof Roach, Prof Sandler, Prof Ponsky, Dr Morgan among many others
Wonderful @NRGonc meeting with strong representation from @RadOncUH with @KashaniRojano @lauren_henke @angela_jia_ and more! Leading so many important concepts. Proud of this amazing team.
@NRGonc GU core committee leading the charge. Honored to chair the intact subcommittee and kudos to @DrPaulNguyen for continuing the legacy of @felixfengmd Amazing concepts coming down the pipeline, multiple led by @RadOncUH investigators
Please join us in welcoming @DrRanaMcKay as our new Section Editor for Genitourinary Disease! Dr. McKay is a medical oncologist who specializes in treating people with urogenital cancers. Her research interests include precision medicine and biomarker development. @OncoAlert
We are thrilled to continue to be a leading center in radiation oncology with another very exciting collaboration to be the first in the USA to have the most advanced rotational arc cobalt SRS unit available to date (Akesis Galaxy RTI), combined with our amazing LINAC SRS…
UH Seidman Cancer Center is the first medical center in the U.S. to implement the innovative Akesis Galaxy RTi device for patient treatments, while also serving as the flagship site for research and clinical demonstration of this advanced technology. bit.ly/SeidmanX725
As @NicholasZaorsky said, one more Oscar of oncology in my cabinet 😂😂...Thank you so much @QuadShotNews!! @RadOncUH @DrSpratticus @angela_jia_ Thank you @MRoupret and @EurUrolOncol for your support!!! We need level I evidence for sure....
Love seeing my @RadOncUH bestie @angela_jia_ and my old co-resident John Floberg from @UW_RadoncDHO setting the pace, presenting GU updates for the Theranostic SubCommittee here @NRGonc ! Power duo! 💥
14/14 Here is the link to the fundraising page. Any gift, small or large, is so appreciated. secure-give.rmh-newyork.org/fundraiser/641…
Congratulations to all new FASCOs! So happy to see so many wonderful friends and inspiring colleagues recognized. Proud to be part of this community. #ASCO #FASCO #Oncology @ASCO @ASCOPres @umangtalking @TiansterZhang @apolo_andrea @drteplinsky @ErikaHamilton9 @jrgralow
Join us in congratulating the following members on earning the Fellows of ASCO (FASCO) distinction last quarter! We are grateful for their extraordinary volunteer service, dedication, and commitment to ASCO. Learn more about FASCO distinction: brnw.ch/21wUiVu
Thank you, @ASCO, for this great honor. Truly humbled to receive the FASCO designation and proud to be part of a community so deeply committed to advancing cancer care and supporting one another. Grateful to serve alongside such inspiring colleagues. #FASCO #oncology
I am not aware of any better speakers on the topic of GI radiation oncology than @KrishanJethwa. Everything just becomes crystal clear. This is why you want to attend @MayoCancerCare CME courses in heme/onc. Quality updates for practitioners. @MayoHemeOnc
Brief 🧵 1/ How common is *failure* of modern active surveillance (AS) for #ProstateCancer (PCa)? Which patients are at higher risk? Spoiler 🚨: it’s pretty simple @EurUrolOncol @UroToday @OncoAlert @PCF_Science @gu_onc @AmerUrological @Uroweb
Just came online in @TheLancet 👉Our two papers on improved OS with Enzalutamide + Talazoparib in mCRPC #ProstateCancer in all-comer & HRRm patients (Median OS and HRs👇). Weblinks to the papers👉 bit.ly/4lXkLtB and bit.ly/4nNIyOh @PCFnews @urotoday @OncoAlert
Just in👉Two @TheLancetOncol papers on patient-reported QOL results in ph3 TALAPRO-2 trial👉in all-comer & HRR deficient mCRPC #ProstateCancer pts👉Improved OS without compromising QOL👇Links: bit.ly/3DWHlSR & bit.ly/3E3SSQi @urotoday @OncoAlert @PCFnews 👇
Go @angela_jia_ !! Already a visiting prof @MayoAZRadOnc just 3 yrs into being an attending, an expert of GU & radiopharms w/ a @Novartis funded Phase I/II trial (⭐️STARLiT, NCT06574880), not to mention PI of METANOVA + future @NRGonc trial leadership. And the best APD on the 🌎
We hosted Dr. Angela Jia as a visiting professor at Mayo Clinic. An absolute superstar in our field — and her impact is only growing. Angela is one of only two radiation oncologists on the @NCCN Kidney Cancer Guidelines Panel @DrSpratticus @NicholasZaorsky 1/x
Congrats to Dr. Janice Lyons of @RadOncUH @caseccc on being named a Fellow of @ASTRO_org🥳🎉 Officially FASTRO!! Amazing news!! @DrSpratticus @NicholasZaorsky @PranshuMohindra @angela_jia_ @UHhospitals @RohanPatelMD @C_PisanoDO @m_paschall
🚨🚨 Just announced: 43 distinguished members named ASTRO Fellow Congratulations to all & thank you for your contributions to ASTRO & the specialty! 🎉🎉🎉 ow.ly/1rKh50WnhSn
Check out the ROECSG update for July 2025 #RadOnc #MedEd - mailchi.mp/roecsg/7-2025u…